Clinical Trials Register

Trials with a EudraCT protocol (765)
Paediatric studies in scope of Art45 of the Paediatric Regulation (2)

765 result(s) found for: colon cancer. Displaying page 10 of 39.

EudraCT Number: 2014-002003-25

Sponsor Protocol Number:

Start Date*: 2016-06-02

Sponsor Name:Barts Health NHS Trust

Full Title: A Phase II Trial of Aflibercept Monotherapy With Early Dynamic Contrast Enhanced Ultrasound Monitoring in Chemorefractory Metastatic Colorectal Cancer

Medical condition: Metastatic Colorectal Cancer

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	20.0	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10061451	Colorectal cancer	PT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: GB (Prematurely Ended)

Trial results: View results

EudraCT Number: 2018-000070-30

Sponsor Protocol Number: LOGIC01

Start Date*: 2018-03-06

Sponsor Name:Aarhus University Hospital

Full Title: IMPROVE Intervention Trial: Implementing non-invasive circulating tumor DNA analysis to optimize the operative and postoperative treatment for patients with colorectal cancer IMPROVE IT

Medical condition: Colorectal cancer patients

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	21.0	100000004864	10010029	Colorectal cancer NOS	LLT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: DK (Prematurely Ended)

Trial results: (No results available)

EudraCT Number: 2009-016591-68

Sponsor Protocol Number: 09.15

Start Date*: 2009-12-22

Sponsor Name:Odense University Hospital

Full Title: Placebo-controlled trial investigating the effect of Vitamin K3-lotion for the treatment of cetuximab induced folliculitis

Medical condition: Cancer patients experiencing folliculitis due to treatment with cetuximab

Disease:	Version	SOC Term	Classification Code	Term	Level
	12.0		10061451	Colorectal cancer	LLT
	12.0		10067821	Head and neck cancer	LLT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: DK (Prematurely Ended)

Trial results: View results

EudraCT Number: 2006-003147-23

Sponsor Protocol Number: IMCL CP11-0602

Start Date*: 2007-06-20

Sponsor Name:ImClone Systems Incorporated

Full Title: Estudio de Fase 2 abierto, multicentrico para evaluar la eficacia y tolerancia del IMC-11F8 en combinación con 5-FU/FA y Oxaliplatino (Folfox-6 modificado) en paciente con un cáncer colorectal no t...

Medical condition: Cancer de colon localmente avanzado y/o metastasico

Disease:	Version	SOC Term	Classification Code	Term	Level
	9.1		10052362	Metastatic colorectal cancer	LLT
	9.1		10010035	Colorectal cancer stage IV	LLT
	9.1		10010034	Colorectal cancer stage III	LLT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: ES (Completed) BE (Completed)

Trial results: View results

EudraCT Number: 2017-002323-25

Sponsor Protocol Number: AA1720

Start Date*: 2017-09-22

Sponsor Name:Center for cancer immune therapy

Full Title: Adoptive cell therapy across cancer diagnoses

Medical condition: Patients with metastatic solid cancers in stages III or IV regardless of diagnosis.

Disease:	Version	SOC Term	Classification Code	Term	Level
	20.0	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10055099	Ocular cancer metastatic	PT
	20.0	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10055100	Otic cancer metastatic	PT
	20.0	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10055108	Thymic cancer metastatic	PT
	20.0	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10050017	Lung cancer metastatic	PT
	20.0	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10059514	Small cell lung cancer metastatic	PT
	20.0	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10059515	Non-small cell lung cancer metastatic	PT
	20.0	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10055104	Pharyngeal cancer metastatic	PT
	20.0	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10055105	Sinus cancer metastatic	PT
	20.0	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10055096	Anal cancer metastatic	PT
	20.0	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10053548	Gastrointestinal cancer metastatic	PT
	20.0	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10055097	Rectal cancer metastatic	PT
	20.0	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10055114	Colon cancer metastatic	PT
	20.0	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10052358	Colorectal cancer metastatic	PT
	20.0	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10055098	Oral cavity cancer metastatic	PT
	20.0	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10055109	Tongue cancer metastatic	PT
	20.0	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10055102	Oesophageal cancer metastatic	PT
	20.0	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10050018	Renal cancer metastatic	PT
	20.0	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10046394	Ureteric cancer metastatic	PT
	20.0	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10046433	Urethral cancer metastatic	PT
	20.0	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10055115	Skin cancer metastatic	PT
	20.0	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10055101	Bone cancer metastatic	PT
	20.0	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10055095	Adrenal gland cancer metastatic	PT
	20.0	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10055106	Pituitary cancer metastatic	PT
	20.0	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10055107	Thyroid cancer metastatic	PT
	20.0	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10055113	Breast cancer metastatic	PT
	20.0	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10055111	Biliary cancer metastatic	PT
	20.0	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10066879	Gallbladder cancer metastatic	PT
	20.0	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10055110	Hepatic cancer metastatic	PT
	20.0	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10055094	Cervix cancer metastatic	PT
	20.0	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10014734	Endometrial cancer metastatic	PT
	20.0	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10016182	Fallopian tube cancer metastatic	PT
	20.0	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10033158	Ovarian epithelial cancer metastatic	PT
	20.0	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10057529	Ovarian cancer metastatic	PT
	20.0	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10046887	Vaginal cancer metastatic	PT
	20.0	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10047742	Vulval cancer metastatic	PT
	20.0	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10036909	Prostate cancer metastatic	PT
	20.0	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10055103	Testicular cancer metastatic	PT
	20.0	100000016906	10033605	Pancreatic cancer metastatic	LLT
	20.0	100000016840	10023183	Jejunum cancer metastatic	LLT
	20.0	100000016840	10013816	Duodenal cancer metastatic	LLT
	20.0	100000016840	10023167	Jejunal cancer metastatic	LLT
	20.0	100000017543	10038498	Renal pelvis and ureter transitional cell cancer metastatic	LLT
	20.0	100000017543	10038509	Renal pelvis and ureteric cancer metastatic transitional cell	LLT
	20.0	100000017725	10046377	Ureter cancer metastatic	LLT
	20.0	100000017773	10046420	Urethra cancer metastatic	LLT
	20.0	100000021146	10036947	Prostatic cancer metastatic	LLT
	20.0	100000016931	10062478	Esophageal cancer metastatic	LLT
	20.0	100000143841	10063107	Tubular breast cancer metastatic	LLT
	20.0	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10068694	Testicular germ cell cancer metastatic	PT
	20.0	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10068971	Germ cell cancer metastatic	PT
	20.0	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10069728	Rectosigmoid cancer metastatic	PT
	20.0	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10069730	Large cell lung cancer metastatic	PT
	20.0	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10070902	Laryngeal cancer metastatic	PT
	20.0	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10071540	Head and neck cancer metastatic	PT
	20.0	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10072792	Tonsil cancer metastatic	PT
	20.0	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10079104	Nasopharyngeal cancer metastatic	PT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: DK (Completed)

Trial results: View results

EudraCT Number: 2019-004679-37	Sponsor Protocol Number: GECOP-MMC	Start Date*: Information not available in EudraCT
Sponsor Name:Hospital Universitario de Fuenlabrada
Full Title: Phase IV multicentric clinical trial to evaluate the efficacy of hyperthermic intraperitoneal chemotherapy (HIPEC) with Mytomicin-C after complete surgical cytoreduction in patients with Colon Canc...
Medical condition: Surgical resection combined with intraperitoneal chemotherapy (CT) is the best treatment for selected patients with Peritoneal Metastases from colon cancer. However, the real role of intraperitonea...
Disease:
Population Age: Adults, Elderly		Gender: Male, Female
Trial protocol: ES (Ongoing)
Trial results: (No results available)

EudraCT Number: 2010-020121-41

Sponsor Protocol Number: 11728

Start Date*: 2011-01-17

Sponsor Name:Bayer Health Care AG, D-51368 Leverkusen

Full Title: An uncontrolled, open-label, phase II study in subjects with metastatic adenocarcinoma of the colon or rectum who are receiving first line chemotherapy with mFOLFOX6 (oxaliplatin/ folinic acid/5-fl...

Medical condition: Metastatic adenocarcinoma of the colon or rectum (metastatic CRC)

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	16.1	100000004864	10052362	Metastatic colorectal cancer	LLT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: GB (Completed) DE (Completed) BE (Completed) ES (Completed) IT (Completed)

Trial results: View results

EudraCT Number: 2019-000935-15	Sponsor Protocol Number: PRODIGE70-CIRCULATE	Start Date*: 2019-09-10
Sponsor Name:Centre Hospitalier Universitaire (CHU) de Dijon
Full Title: CIRCULATE- CIRCULATING TUMOR DNA BASED DECISION FOR ADJUVANT TREATMENT IN COLON CANCER STAGE II
Medical condition: stage II colon cancer, after tumour resection
Disease:
Population Age: Adults, Elderly		Gender: Male, Female
Trial protocol: FR (Trial now transitioned)
Trial results: (No results available)

EudraCT Number: 2009-010417-73

Sponsor Protocol Number: GEMCAD-0901

Start Date*: 2009-06-12

Sponsor Name:Grupo Cooperativo GEMCAD (Grupo Español Multidisciplinar en Cáncer Digestivo)

Full Title: Estudio abierto, no aleatorizado, multicéntrico, en fase II, para evaluar la eficacia y seguridad de Bevacizumab en combinación con Capecitabina y Oxaliplatino, como primera línea de tratamiento en...

Medical condition: Adenocarcinoma Colorrectal Metastásico

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	9.1		10061451	Colorectal cancer	LLT

Population Age: Elderly

Gender: Male, Female

Trial protocol: ES (Ongoing)

Trial results: (No results available)

EudraCT Number: 2011-003958-85

Sponsor Protocol Number: IMM-101-007

Start Date*: 2012-02-03

Sponsor Name:Immodulon Therapeutics Ltd

Full Title: A Phase II, Single Arm, Investigative Study of IMM-101 in Combination with Radiation Induced Tumour Necrosis in Patients with Previously Treated Colorectal Cancer

Medical condition: Metastatic colorectal cancer

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	14.0	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10061451	Colorectal cancer	PT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: GB (Completed)

Trial results: View results

EudraCT Number: 2015-002773-38

Sponsor Protocol Number: AIO-KRK-0214

Start Date*: 2016-12-20

Sponsor Name:AIO-Studien-gGmbH

Full Title: mFOLFOX6 vs. mFOLFOX6 + aflibercept as neoadjuvant treatment in MRI-defined T3-rectal cancer: a randomized phase-II-trial

Medical condition: Patients with locally advanced rectal or rectosigmoid cancer staged cT3 CRM-negative with MRI

Disease:	Version	SOC Term	Classification Code	Term	Level
	20.0	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10010036	Colorectal carcinoma	LLT
	21.0	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10052360	Colorectal adenocarcinoma	PT
	21.0	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10061451	Colorectal cancer	PT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: DE (Completed) AT (Completed)

Trial results: View results

EudraCT Number: 2013-005428-41

Sponsor Protocol Number: 02044190615-01

Start Date*: 2014-12-01

Sponsor Name:Department of experimental and clincial medicine "F. Magrassi"

Full Title: Phase III study of RegorAfenib VErsus placebo as maintenance therapy in RAS wiLd type metastatic coLOrectal cancer

Medical condition: The present proposal is aimed to evaluate the efficacy and safety of regorafenib as maintenance therapy in increasing the efficacy of the best available therapy for first line treatment fluoropirim...

Disease:	Version	SOC Term	Classification Code	Term	Level
	18.0	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10052358	Colorectal cancer metastatic	PT
	18.0	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10052362	Metastatic colorectal cancer	LLT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: DE (Prematurely Ended) ES (Ongoing)

Trial results: (No results available)

EudraCT Number: 2006-005023-42

Sponsor Protocol Number: D4200C00048

Start Date*: 2007-05-16

Sponsor Name:AstraZeneca AB

Full Title: A phase II, double-blind, placebo controlled, randomised study to assess the efficacy and safety of 2 doses of ZACTIMA (ZD6474) in combination with FOLFIRI vs. FOLFIRI alone for the treatment of co...

Medical condition: colorectal cancer

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	8.1		10061451	Colorectal cancer	LLT

Population Age:

Gender: Male, Female

Trial protocol: GB (Completed)

Trial results: View results

EudraCT Number: 2015-005325-39

Sponsor Protocol Number: ELX-NPP-2016-01

Start Date*: 2016-04-26

Sponsor Name:Dr. Antonio Arroyo Sebastián

Full Title: A RANDOMIZED, CONTROLLED, CLINICAL TRIAL TO COMPARE PERIPHERAL PARENTERAL NUTRITION (PeriOlimel N4-E) VS CONVENTIONAL FLUID THERAPY IN ENHANCED RECOVERY AFTER SURGERY (ERAS) PROTOCOL IN COLORECTAL ...

Medical condition: Cancer colorectal

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	19.0	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10061451	Colorectal cancer	PT

Population Age: Elderly

Gender: Male, Female

Trial protocol: ES (Ongoing)

Trial results: (No results available)

EudraCT Number: 2021-001328-17	Sponsor Protocol Number: IMIB-HTF-2021-01	Start Date*: 2021-09-23
Sponsor Name:Fundación para la formación e investigación sanitarias de la Región de Murcia
Full Title: Histological and clinical effects of Imipramine in the treatment of patients with cancer over-expressing Fascin1.
Medical condition: Colorectal cancer and triple negative breast cancer patients (TNBC) who shown overexpression of fascin1 in the diagnostic biopsy tissue.
Disease:
Population Age: Adults, Elderly		Gender: Male, Female
Trial protocol: ES (Ongoing)
Trial results: (No results available)

EudraCT Number: 2016-002393-12

Sponsor Protocol Number: PRODIGE49

Start Date*: 2016-08-26

Sponsor Name:Fédération Francophone de Cancérologie Digestive

Full Title: Systemic oxaliplatin or in intra-arterial chemotherapy combined with LV5FU2 and targeted therapy in first-line treatment of metastatic colorectal cancer restricted to the liver

Medical condition:

Disease:	Version	SOC Term	Classification Code	Term	Level
	19.1	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10052358	Colorectal cancer metastatic	PT
	19.1	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10052362	Metastatic colorectal cancer	LLT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: FR (Trial now transitioned) BE (Trial now transitioned)

Trial results: (No results available)

EudraCT Number: 2020-001588-10

Sponsor Protocol Number: VIVA

Start Date*: 2021-09-27

Sponsor Name:IRCCS-A.O.U. SAN MARTINO-IST

Full Title: A randomized, phase IIb study of adjuvant durvalumab (MEDI4736) plus regorafenib vs untreated control in stage IV colorectal cancer patients with no evidence of disease (NED): VIVA trial

Medical condition: stage IV colorectal cancer patients with no evidence of disease (NED)

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	21.0	100000004864	10001172	Adenocarcinoma of colon stage IV	LLT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: IT (Trial now transitioned)

Trial results: (No results available)

EudraCT Number: 2013-002308-15

Sponsor Protocol Number: PR001

Start Date*: 2013-11-11

Sponsor Name:Guys & St. Thomas' NHS Foundation Trust

Full Title: A phase I/II dose finding study evaluating the safety and tolerability of CAPecitabine and AflIbercept in patients with unresectable metasTAtic colorectaL cancer deemed unsuitable for doublet/ trip...

Medical condition: Colorectal Cancer

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	20.0	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10061451	Colorectal cancer	PT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: GB (GB - no longer in EU/EEA)

Trial results: (No results available)

EudraCT Number: 2005-001012-41

Sponsor Protocol Number: ML18523

Start Date*: 2005-11-29

Sponsor Name:ROCHE

Full Title: Phase II Study of the Combination of Bevacizumab (rhuMAb VEGF) and Oxaliplatin plus Capecitabine (XELOX) in Patients with Advanced Colorectal Cancer

Medical condition: Patients with inoperable locally advanced or metastatic colorectal cancer, who have not previosly received systemic treatment for metastatic disease.

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	14.1	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10061451	Colorectal cancer	PT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: IT (Completed)

Trial results: View results

EudraCT Number: 2011-000765-12

Sponsor Protocol Number: MICORYX

Start Date*: 2011-08-22

Sponsor Name:Oryx GmbH & Co. KG

Full Title: Phase I/IIa study of immunization with frameshift peptides administered with Montanide ISA-51 VG in patients with advanced MSI-H colorectal cancer

Medical condition: advanced MSI-H colorectal cancer

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	14.1	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10061451	Colorectal cancer	PT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: DE (Completed)

Trial results: (No results available)

Subscribe to this Search
To subscribe to the RSS feed for this search click here

. This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.

Download Options:
Number of Trials to download:

Download Content:

Download Format:


Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial.

Query did not match any studies.

Select Country:	Select Age Range:
Select Trial Status:	Select Trial Phase:
Select Gender:
Select Date Range: to
Select Rare Disease:
IMP with orphan designation in the indication
Orphan Designation Number:
Results Status:
Clear advanced search filters

Austria
Belgium
Bulgaria
Croatia
Cyprus
Czechia
Denmark
Estonia
Finland
France
Germany
Greece
Hungary
Iceland
Ireland
Italy
Latvia
Liechtenstein
Lithuania
Luxembourg
Malta
Netherlands
Norway
Poland
Portugal
Romania
Slovakia
Slovenia
Spain
Sweden
United Kingdom
Outside EU/EEA

Clinical trials for colon cancer